c-Maf: a bad influence in the education of macrophages

Insights

The c-Maf transcription factor drives tumor growth by promoting immunosuppressive tumor-associated macrophages (TAMs). Inhibiting c-Maf or using β-glucan may offer new cancer immunotherapies.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Tumor-associated macrophages (TAMs) are key regulators of the tumor microenvironment.
  • TAMs typically promote tumor progression, immunosuppression, and angiogenesis.
  • The precise mechanisms controlling TAM polarization remain incompletely understood.

Purpose of the Study:

  • To identify key regulators of protumoral TAM polarization.
  • To investigate the role of the c-Maf transcription factor in TAM function.
  • To explore therapeutic strategies targeting c-Maf in cancer.

Main Methods:

  • Analysis of c-Maf's role in myeloid cell differentiation and function.
  • Inhibition of c-Maf in myeloid progenitors and subsequent analysis of tumor growth.
  • Assessment of β-glucan's effect on c-MAF expression in cancer patient cells.

Main Results:

  • c-Maf was identified as a master regulator of protumoral TAM polarization.
  • c-Maf promotes TAM immunosuppressive activity, metabolic programming, and CSF1R expression.
  • Inhibition of c-Maf delayed tumor growth; β-glucan reduced c-MAF expression in NSCLC patient cells.

Conclusions:

  • c-Maf is a critical driver of myeloid cell-mediated cancer progression.
  • Targeting c-Maf presents a potential strategy for cancer immunotherapy.
  • Understanding c-Maf's role may lead to treatments for various solid malignancies.